Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYL
2251
CALL
DELISTED
RYLAND GROUP INC
RYL
| $2.64M | ﹤0.01% |
66,100
-18,000
| -21% | -$693K |
|
2252
PUT
FirstEnergy
FE
$27.1B
| $2.64M | ﹤0.01% |
73,400
-239,600
| -77% | -$9M |
|
2253
CALL
Nabors Industries
NBR
$1.33B
| $2.64M | ﹤0.01% |
3,302
+776
| +31% | +$610K |
|
2254
CALL
Boston Properties
BXP
$10.8B
| $2.64M | ﹤0.01% |
24,900
+12,800
| +106% | +$1.35M |
|
|
OCSI
2255
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $2.64M | ﹤0.01% |
+202,750
| New | +$2.83M |
|
|
OA
2256
DELISTED
Orbital ATK, Inc.
OA
| $2.63M | ﹤0.01% |
27,142
+4,031
| +17% | +$382K |
|
2257
Sun Life Financial
SLF
$45.8B
| $2.63M | ﹤0.01% |
84,877
-2,065
| -2% | -$65.6K |
|
|
INVX
2258
Innovex International
INVX
$2.04B
| $2.63M | ﹤0.01% |
23,037
-27,418
| -54% | -$2.8M |
|
2259
CALL
Sherwin-Williams
SHW
$88.1B
| $2.62M | ﹤0.01% |
43,200
+14,100
| +48% | +$828K |
|
2260
Moog Inc Class A
MOG.A
$13B
| $2.62M | ﹤0.01% |
45,184
-10,599
| -19% | -$587K |
|
|
ARIA
2261
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.62M | ﹤0.01% |
145,400
+92,800
| +176% | +$1.8M |
|
2262
PUT
Neurocrine Biosciences
NBIX
$16.8B
| $2.62M | ﹤0.01% |
237,600
+198,400
| +506% | +$2.73M |
|
2263
CALL
Healthpeak Properties
DOC
$14.4B
| $2.61M | ﹤0.01% |
71,590
+46,556
| +186% | +$1.82M |
|
2264
Rithm Capital
RITM
$5.65B
| $2.6M | ﹤0.01% |
217,097
+66,222
| +44% | +$867K |
|
|
CVSA
2265
PUT
Covista Inc
CVSA
$4.38B
| $2.6M | ﹤0.01% |
86,800
+82,000
| +1,708% | +$2.53M |
|
2266
CALL
Innoviva
INVA
$1.49B
| $2.6M | ﹤0.01% |
80,789
-11,914
| -13% | -$370K |
|
|
IHS
2267
DELISTED
IHS INC CL-A COM STK
IHS
| $2.6M | ﹤0.01% |
22,830
+7,807
| +52% | +$859K |
|
2268
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.74B
| $2.59M | ﹤0.01% |
44,711
+5,679
| +15% | +$321K |
|
|
EXPR
2269
DELISTED
Express, Inc.
EXPR
| $2.59M | ﹤0.01% |
5,637
-57
| -1% | -$25.2K |
|
|
PKY
2270
DELISTED
Parkway, Inc.
PKY
| $2.59M | ﹤0.01% |
152,629
+71,469
| +88% | +$1.25M |
|
|
SWFT
2271
DELISTED
Swift Transportation Company
SWFT
| $2.59M | ﹤0.01% |
129,704
+18,801
| +17% | +$342K |
|
2272
CALL
Polaris
PII
$3.97B
| $2.59M | ﹤0.01% |
20,100
-3,500
| -15% | -$393K |
|
|
RUE
2273
DELISTED
RUE21 INC COM STK (DE)
RUE
| $2.59M | ﹤0.01% |
64,799
-1,141
| -2% | -$47.2K |
|
|
MXIM
2274
PUT
DELISTED
Maxim Integrated Products
MXIM
| $2.59M | ﹤0.01% |
89,200
-24,900
| -22% | -$708K |
|
|
IMGN
2275
DELISTED
Immunogen Inc
IMGN
| $2.58M | ﹤0.01% |
151,992
+8,371
| +6% | +$147K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.